Showing results (1-10 of 201) with videos related to
Sort By:
Pageof 21
Hematology/Oncology Clinics of North America|June 24, 2019
Noncellular Immune Therapies for Non-Hodgkin LymphomaAlex F HerreraHematology. American Society of Hematology. Education Program|December 4, 2018
Where does PD-1 blockade fit in HL therapy?Alex F HerreraJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2017
Minimal Residual Disease Assessment in Lymphoma: Methods and ApplicationsAlex F Herrera, Philippe ArmandBlood Advances|December 4, 2024
New strategies for enhancing enrollment of underrepresented minorities in lymphoma clinical trialsChijioke Nze, Alex F HerreraBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 15, 2021
Advances in Immunotherapy for Diffuse Large B Cell LymphomaGeoffrey Shouse, Alex F HerreraBlood|April 23, 2021
How I incorporate novel agents into the treatment of classical Hodgkin lymphomaNarendranath Epperla, Alex F HerreraClinical Lymphoma, Myeloma & Leukemia|May 29, 2018
Investigational Antibody-Drug Conjugates for Treatment of B-lineage MalignanciesAlex F Herrera, Arturo MolinaTherapeutic Advances in Hematology|September 14, 2018
Update on the role of brentuximab vedotin in classical Hodgkin lymphomaSarah Tomassetti, Alex F HerreraHematology. American Society of Hematology. Education Program|December 9, 2022
Incorporating novel agents into frontline treatment of Hodgkin lymphomaSwetha Kambhampati Thiruvengadam, Alex F HerreraCurrent Hematologic Malignancy Reports|August 24, 2018
Updates on Circulating Tumor DNA Assessment in LymphomaJustin M Darrah, Alex F HerreraPageof 21